Characterization of Metabolic Reprogramming in Head and Neck Squamous Cell Carcinoma and Application Prospects for Targeted Therapy

Head and neck squamous cell carcinoma (HNSCC) is the seventh most common malignant tumor in the world, with a 5-year survival rate of only about 50%. Thus, discovering more effective diagnostic and therapeutic approaches is an urgent need. The metabolic reprogramming of tumor cells is a key feature...

Full description

Saved in:
Bibliographic Details
Published inZhongliu fangzhi yanjiu Vol. 51; no. 12; pp. 1046 - 1050
Main Authors Wang, Ruilin, Ma, Yuxiu, Liu, Xuelin, Zhang, Qi, Wang, Guoyin, Li, Hongling
Format Journal Article
LanguageChinese
English
Published Tianjin China Anti-Cancer Association 01.12.2024
Magazine House of Cancer Research on Prevention and Treatment
Subjects
Amino acids
Biological activity
Biosynthesis
Complexity
Glycolysis
Head and neck carcinoma
head and neck squamous carcinoma
Lipid metabolism
Lipids
Medical prognosis
metabolic reprogramming
Metabolism
Metastases
Squamous cell carcinoma
targeted therapy
therapeutic strategies
Therapeutic targets
Tumor cells
Tumor microenvironment
Tumors
Online AccessGet full text

Cover

More Information
Summary:Head and neck squamous cell carcinoma (HNSCC) is the seventh most common malignant tumor in the world, with a 5-year survival rate of only about 50%. Thus, discovering more effective diagnostic and therapeutic approaches is an urgent need. The metabolic reprogramming of tumor cells is a key feature in the development of HNSCC, which widely exhibits alterations in glycolytic metabolism, lipid metabolism, and amino acid metabolism compared with normal cells. Metabolic reprogramming affects the energy supply and biosynthesis of tumor cells. It also participates in the regulation of the tumor microenvironment and promotes key biological processes such as proliferation, invasion, and metastasis of HNSCC. With the progressive understanding of the complexity of tumor biology, targeted-therapy strategies against metabolic reprogramming in HNSCC are emerging as a promising therapeutic approach. These metabolically targeted therapies have performed well in preclinical studies, but their clinical application requires further validation. In the future, we need to deeply explore the more complex features of metabolic reprogramming and its biological significance in HNSCC, with the aim of discovering more effective diagnostic and therapeutic targets, as well as providing new strategies to improve the prognosis of HNSCC patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:1000-8578
DOI:10.3971/j.issn.1000-8578.2024.24.0545